CAM-FAP / Precirix - LARVOL DELTA

Tom Plitz commences role as Chief Executive Officer of Precirix (Precirix Press Release) - "Precirix...today announces that Tom Plitz has been appointed CEO of the company. Former CEO, Ruth Devenyns, will remain in an advisory role for the next month to ensure a smooth transition. The company is furthermore reinforcing its team of experts and received additional financial support from its investors to drive CAM-FAP towards the clinic and define the clinical development plan of CAM-H2."

Financing • Breast Cancer • Gastric Cancer • Gastroesophageal Cancer • Gastrointestinal Cancer • HER2 Breast Cancer • HER2 Positive Breast Cancer • Oncology • Solid Tumor